Ginkgo Bioworks Holdings DNA
NYSE DNA
$11.99 +1.53 (+14.67%)
As of: Sep 29, 2026 · 3:59 PM EDT

Ginkgo Bioworks Holdings (DNA) Research & Development (2020 - 2026)

Updated

Ginkgo Bioworks Holdings (DNA) posted Research & Development of $46.21 million for Q2 2026, down 13.4% from $53.37 million a year earlier and down 7.4% from the prior quarter.

Analysis

Ginkgo Bioworks Holdings (DNA) Research & Development (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Research & Development at Ginkgo Bioworks Holdings was $215.61 million, down 22.4% year-over-year; for FY2025, it came in at $243.77 million, down 42.5% from FY2024.

  • Annual Research & Development has declined for four consecutive years, though with a five-year compound annual growth rate of 8.8% (FY2020 to FY2025).
  • In prior years, Ginkgo Bioworks Holdings' Research & Development was $424.06 million in FY2024 (-27.0%), $580.62 million in FY2023 (-44.8%), $1.05 billion in FY2022 (-8.4%) and $1.15 billion in FY2021 (+619.6%).
  • The Q2 2026 figure stands as the lowest quarterly Research & Development since Q3 2020.
  • On a year-over-year basis, Research & Development has declined in each of the last 15 quarters, with an average decline of 35.1% over the last eight quarters.
  • The strongest year-over-year quarter for Research & Development in the past five years was Q2 2022, with growth of 457.5%; the weakest was Q4 2022, with a decline of 82.0%.
  • According to Business Quant data, Research & Development for the three prior quarters was $49.92 million (Q1 2026), $50.13 million (Q4 2025) and $69.35 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Iqvia Holdings 44.55 Bn 36.39 Bn 1.44 Bn -
2 Medpace Holdings 17.19 Bn 15.25 Bn 201.64 Mn -
3 Charles River Laboratories International 14.06 Bn 13.30 Bn 363.37 Mn -
4 Icon 13.44 Bn 10.55 Bn 479.29 Mn -
5 Fortrea Holdings 1.91 Bn 1.29 Bn 139.20 Mn -
6 Ginkgo Bioworks Holdings 665.78 Mn -96.30 Mn 18.44 Mn 46.21 Mn
7 Evotec SE 565.34 Mn -1.01 Bn - -
8 Champions Oncology 68.06 Mn 43.71 Mn 7.70 Mn 2.34 Mn
9 MindWalk Holdings 62.59 Mn 26.81 Mn 1.61 Mn 921,603.43
10 Natural Alternatives International 10.67 Mn -22.35 Mn 383,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 46.21 Mn
Mar 31, 2026 49.92 Mn
Dec 31, 2025 50.13 Mn
Sep 30, 2025 69.35 Mn
Jun 30, 2025 53.37 Mn
Mar 31, 2025 70.92 Mn
Dec 31, 2024 76.38 Mn
Sep 30, 2024 77.01 Mn
Jun 30, 2024 134.22 Mn
Mar 31, 2024 136.46 Mn
Dec 31, 2023 117.04 Mn
Sep 30, 2023 156.66 Mn
Jun 30, 2023 144.28 Mn
Mar 31, 2023 162.64 Mn
Dec 31, 2022 177.55 Mn
Sep 30, 2022 261.46 Mn
Jun 30, 2022 290.06 Mn
Mar 31, 2022 323.58 Mn
Dec 31, 2021 985.03 Mn
Sep 30, 2021 53.02 Mn
API Access

Ginkgo Bioworks Holdings Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=DNA&period=max&api_key=YOUR_API_KEY